EBV persistence in memory B cells in vivo

Immunity

Volumn 9, Issue 3, 1998, Pages 395-404

  Babcock, Gregory J ^a   Decker, Lisa L ^a   Volk, Mark ^b   Thorley Lawson, David A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN D;

ARTICLE; B LYMPHOCYTE; BLAST CELL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MEMORY CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; TONSIL; VIRUS LATENCY;

EID: 0032168828     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80622-6     Document Type: Article

References (30)

1. Anagnostopoulos, I., Hummel, M., Kreschel, C., and Stein, H. (1995). Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85, 744-750.
2. Beaufils, P., Choquet, D., Mamoun, R.Z., and Malissen, B. (1993). The (YXXL/I)2 signaling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events. EMBO J. 12, 5105-5112.
3. Caldwell, R.G., Wilson, J.B., Anderson, S.J., and Longnecker, R. (1998). Epstein-Barr Virus LMP2A Drives B Cell Development and Survival in the Absence of Normal B Cell Receptor Signals. Immunity 9, 405-411.
4. Chen, F., Zou, J.Z., Di Renzo., L., Winberg, G., Hu, L.F., Klein, E., Klein G., and Ernberg, I. (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69, 3752-3758.
5. Deacon, E.M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A.B., and Young, L.S. (1993). Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177, 339-349.
6. Decker, L.L., Klaman, L.D., and Thorley-Lawson, D.A. (1996). Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70, 3286-3289.
7. Gray, D., and Skarvall, H. (1988). B-cell memory is short-lived in the absence of antigen. Nature 336, 70-73.
8. Hurley, E.A., and Thorley-Lawson, D.A. (1988). B cell activation and the establishment of Epstein-Barr virus latency. J. Exp. Med. 168, 2059-2075.
9. Khan, G., Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A. (1996). Is EBV persistence in vivo a model for B cell homeostasis? Immunity 5, 173-179.
10. Khanna, R., Slade, R.W., Poulsen, L., Moss, D.J., Burrows, S.R., Nicholls, J., and Burrows, J.M. (1997). Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift. J. Virol. 71, 8340-8346.
11. Kieff, E. (1996). Epstein-Barr virus and its replication. In Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (New York: Raven Press), pp. 2343-2396.
12. Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., and Hansmann, M.L. (1994). Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. USA 91, 10962-10966.
13. -bearing cells in normal individuals and acute malaria patients. Immunology 82, 383-388.
14. Lam, K.P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083.
15. Liu, Y.J., Arpin, C., de Bouteiller, O., Guret, C., Banchereau, J., Martinez-Valdez, H., and Lebecque, S. (1996). Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin. Immunol. 8, 169-177.
16. MacLennan, I.C. (1994). Germinal centers. Annu. Rev. Immunol. 12, 117-139.
17. MacLennan, I.C., Liu, Y.L., and Ling, N.R. (1988). B cell proliferation in follicles, germinal centre formation and the site of neoplastic transformation in Burkitt's lymphoma. Curr. Top. Microbiol. Immunol. 141, 138-148.
18. Martinez-Valdez, H., Guret, C., de Bouteiller, O., Fugier, I., Banchereau, J., and Liu, Y.J. (1996). Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J. Exp. Med. 183, 971-977.
19. Miyashita, E.M., Yang, B., Lam, K.M., Crawford, D.H., and Thorley-Lawson, D.A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80, 593-601.
20. Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A. (1997). Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71, 4882-4891.
21. p promotor in early passage Burkitt lymphoma cells define a fourth promotor for expression of the EBV EBNA-1 protein. J. Virol. 70, 623-627.
22. Polack, A., Hortnagel, K., Pajic, A., Christoph, B., Baier, B., Falk, M., Mautner, J., Geltinger, C., Bornkamm, G.W., and Kempkes, B. (1996). c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc. Natl. Acad. Sci. USA 93, 10411-10416.
23. Qu, L., and Rowe, D.T. (1992). Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66, 3715-3724.
24. Rickinson, A.B., and Kieff, E. (1996). Epstein-Barr virus. In Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (New York: Raven Press), pp. 2397-2446.
25. Rickinson, A.B., Finerty, S., and Epstein, M.A. (1977). Mechanism of the establishment of Epstein-Barr virus genome-containing lymphoid cell lines from infectious mononucleosis patients: studies with phosphonoacetate. Int. J. Cancer 20, 861-868.
26. Schaefer, B.C., Strominger, J.L., and Speck, S.H. (1995). Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92, 10565-10569.
27. Schittek, B., and Rajewsky, K. (1990). Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 346, 749-751.
28. Tierney, R.J., Steven, N., Young, L.S., and Rickinson, A.B. (1994). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68, 7374-7385.
29. Tough, D.F., and Sprent, J. (1995). Lifespan of lymphocytes, Immunol. Res. 14, 1-12.
30. Yao, Q.Y., Ogan, P., Rowe, M., Wood, M., and Rickinson, A.B. (1989). Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 43, 67-71.